MLYS smart money
Mineralys Therapeutics, INC. (MLYS): 1 insider buy, 6 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$8.8M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-03-31 | Shah Rajeev M. | Director | $8.8M | $23.67 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 24 | Orbimed Advisors LLC | TRIM -31% | 0.68% | $37M |
| 31 | Affinity Asset Advisors, LLC | 1.09% | $19M | |
| 51 | Dafna Capital Management LLC | 0.24% | $1M | |
| 72 | Sphera Funds Management LTD. | TRIM -10% | 5.02% | $33M |
| 76 | Polar Capital Holdings PLC | 0.10% | $36M | |
| 86 | Adar1 Capital Management, LLC | TRIM -24% | 0.27% | $6M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$28M | 2026-06-30 |